Keros Therapeutics Inc.

NASDAQ: KROS · Real-Time Price · USD
13.60
0.13 (0.97%)
At close: May 14, 2025, 3:59 PM
13.59
-0.07%
After-hours: May 14, 2025, 05:40 PM EDT

Keros Therapeutics Revenue

Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending March 31, 2025, Keros Therapeutics generated $211.25M in revenue.
Revenue (ttm)
$3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
$21.01K
Employees
169
Market Cap
552.37M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.